1. M2 Pseudomonas aeruginosa (Pa) biofilm-forming potential and metabolomic phenotypes differ between chronically infected patients with cystic fibrosis (CF) and non-CF bronchiectasis (Bx). (12th November 2019) Authors: Smith, WD; Murphy, RA; Simbo, A; Fletcher, OL; Cameron, SJS; Bardin, EE; Takats, Z; Hogg, C; Filloux, A; Bush, A; Davies, JC Journal: Thorax Issue: Volume 74(2019)Supplement 2 Page Start: A235 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. M5 The multiple sclerosis drug, glatiramer acetate, acts as a resistance breaker with antibiotics from different classes against cystic fibrosis strains of pseudomonas aeruginosa. (12th November 2019) Authors: Murphy, RA; Harrison, J; Schelenz, S; Davies, JC Journal: Thorax Issue: Volume 74(2019)Supplement 2 Page Start: A236 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. The contribution of health behaviours to waist circumference change following employment transitions: Alexander Tam. (25th October 2022) Authors: Tam, ACT; Murphy, RA; Zhang, W; Conklin, AI Journal: European journal of public health Issue: Volume 32(2022)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗